Atorvastatin Epoxy Pyrrolooxazin 6-Hydroxy Analog (USP)
Impureza
Esta molécula é um impureza de Atorvastatin.
Impureza
Atorvastatin Epoxy Pyrrolooxazin 6-Hydroxy Analog (USP)
Cat. No. ANTPRD8989CAS 1316291-19-6ConsulteSintetizado
Dados Técnicos
Cat. No.ANTPRD8989
CAS1316291-19-6
Fórmula Mol.C33H34FN2NaO7
Peso Mol.612.63 g/mol
IUPACsodium 4-[5-(4-fluorophenyl)-5-hydroxy-4-phenyl-2-(phenylcarbamoyl)-1-propan-2-yl-3,10-dioxa-6-azatricyclo[4.4.0.02,4]decan-9-yl]-3-hydroxybutanoate
SMILESCC(C)C12OC(CC(O)CC(=O)[O-])CCN1C(O)(c1ccc(F)cc1)C1(c3ccccc3)OC21C(=O)Nc1ccccc1.[Na+]
InChIInChI=1S/C33H35FN2O7.Na/c1-21(2)33-31(29(40)35-25-11-7-4-8-12-25)30(43-31,22-9-5-3-6-10-22)32(41,23-13-15-24(34)16-14-23)36(33)18-17-27(42-33)19-26(37)20-28(38)39;/h3-16,21,26-27,37,41H,17-20H2,1-2H3,(H,35,40)(H,38,39);/q;+1/p-1
Chave InChIOWLRXFXFFHQDSQ-UHFFFAOYSA-M
Descrição
Visão geral
Atorvastatin Epoxy Pyrrolooxazin 6-Hydroxy Analog (USP), Atorvastatin, 1316291-19-6, sodium 4-[5-(4-fluorophenyl)-5-hydroxy-4-phenyl-2-(phenylcarbamoyl)-1-propan-2-yl-3,10-dioxa-6-azatricyclo[4.4.0.02,4]decan-9-yl]-3-hydroxybutanoate
A Anant Labs é a renomada e autêntica fabricante e fornecedora de Atorvastatin Epoxy Pyrrolooxazin 6-Hydroxy Analog (USP) na Índia.
A Anant tem expertise em química orgânica sintética e análise farmacêutica e fornece serviços de pesquisa personalizados com custo acessível e precisão para a indústria.
Sinônimos
Atorvastatin Cyclic Sodium Salt (Isopropyl) Impuritysodium;4-[5-(4-fluorophenyl)-5-hydroxy-4-phenyl-2-(phenylcarbamoyl)-1-propan-2-yl-3,10-dioxa-6-azatricyclo[4.4.0.02,4]decan-9-yl]-3-hydroxybutanoateSodium 4-(7-(4-fluorophenyl)-7-hydroxy-1b-isopropyl-7a-phenyl-1a-(phenylcarbamoyl)hexahydro-1aH-oxireno[2',3':3,4]pyrrolo[2,1-b][1,3]oxazin-3-yl)-3-hydroxybutanoate7-(4-Fluorophenyl)hexahydro-beta,7-dihydroxy-1b-(1-methylethyl)-7a-phenyl-1a-[(phenylamino)carbonyl]-3H-oxireno[3,4]pyrrolo[2,1-b][1,3]oxazine-3-butanoic Acid Sodium Salt (1:1)ATORVASTATIN CYCLIC SODIUM SALTAtorvastatin Impurity L(Atorvastatin Cyclic Sodium Salt )7-(4-fluorophenyl)hexahydro-?,7-dihydroxy-1b-(1-methylethyl)-7a-phenyl-1 a-[(phenylamino)carbonyl]-3H-Oxireno[3,4]pyrrolo[2,1-b][1,3] oxazine-3-butanoic acid sodiumsodium;4-[5-(4-fluorophenyl)-5-hydroxy-1-isopropyl-4-phenyl-2-(phenylcarbamoyl)-3,10-dioxa-6-azatricyclo[4.4.0.02,4]decan-9-yl]-3-hydroxy-butanoateSodium4-(7-(4-fluorophenyl)-7-hydroxy-1b-isopropyl-7a-phenyl-1a-(phenylcarbamoyl)hexahydro-1aH-oxireno[2',3':3,4]pyrrolo[2,1-b][1,3]oxazin-3-yl)-3-hydroxybutanoate

